Influence of Kangdu Huazhuo Decoction on Capsid Antigen IgA and Early Antigen-IgA Antibodies Infected by EB Virus

WEN Hai-tao; LIU Can-jun

doi:10.13422/j.cnki.syfjx.2015110190

您当前的位置：

首页 >

文章列表页 >

Influence of Kangdu Huazhuo Decoction on Capsid Antigen IgA and Early Antigen-IgA Antibodies Infected by EB Virus

更新时间：2024-01-04

- Influence of Kangdu Huazhuo Decoction on Capsid Antigen IgA and Early Antigen-IgA Antibodies Infected by EB Virus
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 21, Issue 11, Pages: 190-193(2015)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2015110190
  CLC： R285.6
- Published：2015
- 稿件说明：
移动端阅览
WEN Hai-tao, LIU Can-jun. Influence of Kangdu Huazhuo Decoction on Capsid Antigen IgA and Early Antigen-IgA Antibodies Infected by EB Virus[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(11): 190-193.
DOI：

WEN Hai-tao, LIU Can-jun. Influence of Kangdu Huazhuo Decoction on Capsid Antigen IgA and Early Antigen-IgA Antibodies Infected by EB Virus[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(11): 190-193. DOI： 10.13422/j.cnki.syfjx.2015110190.

摘要

目的: 观察抗毒化浊方对EB病毒(EBV)感染患者

EB病毒衣壳抗原IgA抗体(VCA-IgA)和早期抗原-IgA抗体(EA-IgA)的作用及对机体免疫炎症因子的影响. 方法: 将118例EBV抗体阳性患者随机采用数字表法按1:2比例分为对照组37例和实验组81例.对照组采用抗毒化浊方安慰剂口服

实验组采用抗毒化浊方内服

两组疗程均为12周.检测治疗前后VCA-IgA和EA-IgA水平

检测治疗前后T淋巴细胞亚群和自然杀伤细胞(NK)

肿瘤坏死因子-α(TNF-α)

白细胞介素-2(IL-2)和白细胞介素(IL-6)水平. 结果: 治疗后实验组VCA-IgA和EA-IgA水平均低于对照组(P <0.01);治疗后实验组VCA-IgA

EA-IgA阴转率分别为44.15%

41.33%

均高于对照组的19.35%

16.66%(P <0.05);治疗后实验组CD3+

CD4+

CD4+/CD8+和NK水平均比治疗前上升

并高于对照组(P <0.01);治疗后实验组TNF-α和IL-6水平低于对照组

IL-2高于对照组(P <0.01). 结论: 抗毒化浊方能降低EBV抗体阳性患者的VCA-IgA

EA-IgA水平

促使VCA-IgA

EA-IgA转阴

其机制可能是通过调节细胞因子

提高机体免疫功能来实现的.

Abstract

Objective: To observe the effect of Kangdu Huazhuo decoction on capsid antigen IgA (VCA-IgA) and early antigen-IgA (EA-IgA) antibodies of patients infected by the EB virus (EBV)

and to investigate its influence on inflammatory factor of body immunity. Method: One hundred and eighteen patients with positive EB virus (EBV) antibodies were randomly divided into the control group (37 cases) and the experimental group (81 cases) by a random number table. Patients in the control group received placebo of Kangdu Huazhuo decoction

and patients in the experimental group took Kangdu Huazhuo decoction orally. All patients in both two groups received 12 weeks of treatment. Before and after treatment

levels of VCA-IgA

EA-IgA

T lymphocyte subsets

natural killer cell(NK)

tumor necrosis factor-α(TNF-α)

interleukin-2 (IL-2) and interleukin-6 (IL-6) were detected. Result: After treatment

levels of VCA-IgA and EA-IgA in the experimental group were lower than those in the control group (P <0.01). Negative rates of VCA-IgA and EA-IgA in the experimental group were 44.15% and 41.33%

respectively

which were higher than those of 19.35% and 16.66% in the control group (P <0.05). Compared with before

levels of CD3+

CD4+

CD4+/CD8+and NK increased after treatment

and the results were higher in the experimental group (P <0.01). Levels of TNF-α and IL-6 were lower

level of IL-2 was higher in the experimental group than those in the control group after treatment (P <0.01). Conclusion: Kangdu Huazhuo decoction could reduce the levels of VCA-IgA and EA-IgA of patients with positive EBV antibodies

and promote the negative rate of VCA-IgA and EA-IgA. Its mechanism of action may be related to ameliorating cytokines and improving levels of immune function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Protective Effect against Helicobacter pylor Gastritis in Mice by Flavonoid Combinations of Alpiniae Officinarum Rhizoma via Inhibition of PI3K/Akt Pathway

Protective Effect of Taohong Siwutang on Cerebral Ischemia-reperfusion Injury Based on A1/A2 Phenotype Transformation of Astrocytes Mediated by JAK2/STAT3 Pathway

Influence of Guizhi Jia Longgu Mulitang on Expression of IL-10 and TNF-α in Insomnia Rats with Sensory Dysfunction Dominated by Lung

Improvement of Skin Barrier and Anti-inflammatory Mechanism of Huangliansan on Atopic Dermatitis in Mice

Exploring on Mechanism of Gegen Qinliantang in Interventing Antibiotic-associated Diarrhea Based on 16S rRNA Sequencing and Network Pharmacology

Related Author

LUO Xin

ZHENG Wuyinxiao

YANG Jingyu

ZHAN Jianting

MA Haoran

YE Xiaochuan

GAN Guopin

LIU Dan

Related Institution

Hubei Engineering Research Center for Traditional Chinese Medicine Processing

Hubei Key Laboratory of Resource and Chemistry of Chinese Medicine，School of Pharmacy， Hubei University of Chinese Medicine

MOE-Anhui Joint Collaborative Innovation Center for Quality Improvement of Anhui Genuine Chinese Medicinal Materials

Anhui Province Key Laboratory of Chinese Medicinal Formula

School of Pharmacy，Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰